TOLREMO therapeutics AG
Pharmaceuticals - Muttenz, Basel-Landschaft, Switzerland
TOLREMO therapeutics AG Employees
TOLREMO therapeutics AG Senior Management
TOLREMO therapeutics AG Details
TOLREMO therapeutics AG ("TOLREMO") is a Swiss biotechnology company that was spun out of ETH Zurich in 2017. Based on cutting-edge science and guided by pioneering real-world medicine, TOLREMO created a broad cancer drug resistance platform that provides a unique entry point into a major clinical problem. The company develops resistance-breaking add-on therapies that extend the therapeutic benefit of oncogene-targeting cancer drugs by eliminating resistance-causing persister cells (Adaptive Drug Resistance). TOLREMO's unique drug resistance platform has the potential to catalyze a new wave of potent resistance-breaking molecules that will meaningfully extend the lives of patients suffering from cancer. To learn more visit www.tolremo.com.
TOLREMO therapeutics AG Technologies
Fonts
Typekit
Tag Management
Google Tag Manager
Other
Mobile Friendly